Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Haruka TsuchiyaDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, JapanCorrespondence[email protected]

Hirotaka TsunoDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

Mariko InoueDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

Yuko TakahashiDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

Hiroyuki YamashitaDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

Hiroshi KanekoDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

Toshikazu KanoDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

Akio MimoriDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

show all

Click to increase image sizeClick to decrease image size

Acknowledgments

The authors thank Dr. Tsuneyo Mimori of the Department of Rheumatology and Clinical Immunology, Kyoto University for detection of anti-CADM 140 antibody.

Conflict of interest

None.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Information for

Open access

Opportunities

Help and information

Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Acknowledgments

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature